Literature DB >> 9271713

Synergistic effect of two HLA heterodimers in the susceptibility to celiac disease in Tunisia.

F Bouguerra1, M C Babron, J F Eliaou, A Debbabi, J Clot, F Khaldi, L Greco, F Clerget-Darpoux.   

Abstract

The DR and DQ HLA genotypes of 94 Tunisian children affected with celiac disease are analyzed so that we can gain a better understanding of the HLA component of this disease. All of them carry at least one of two specific heterodimers: a DQ heterodimer, encoded by DQA1*0501, DQB1*0201 and/or a DR heterodimer, encoded by the nonpolymorphic gene DRA and the DRB4 gene. Quantifying the relative penetrances of all susceptible genotypes gives evidence for a synergistic effect of these two heterodimers and for a dose effect of the alleles encoding the beta chains of these two heterodimers. The DR3DR7 individuals have the greatest risk. They present the two kinds of heterodimers and carry two DQB1*0201 alleles. Celiac disease is the first HLA-associated disease for which the at-risk genotypes are so well delineated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271713     DOI: 10.1002/(SICI)1098-2272(1997)14:4<413::AID-GEPI6>3.0.CO;2-3

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  9 in total

Review 1.  Celiac disease in Middle Eastern and North African countries: a new burden?

Authors:  Kassem Barada; Abbas Bitar; Mohamad Abdul-Razak Mokadem; Jana Ghazi Hashash; Peter Green
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 2.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

3.  Burden of celiac disease in the Mediterranean area.

Authors:  Luigi Greco; Laura Timpone; Abdelhak Abkari; Mona Abu-Zekry; Thomas Attard; Faouzi Bouguerrà; Paskal Cullufi; Aydan Kansu; Dusanka Micetic-Turk; Zrinjka Mišak; Eleftheria Roma; Raanan Shamir; Selma Terzic
Journal:  World J Gastroenterol       Date:  2011-12-07       Impact factor: 5.742

4.  Genome search in celiac disease.

Authors:  L Greco; G Corazza; M C Babron; F Clot; M C Fulchignoni-Lataud; S Percopo; P Zavattari; F Bouguerra; C Dib; R Tosi; R Troncone; A Ventura; W Mantavoni; G Magazzù; R Gatti; R Lazzari; A Giunta; F Perri; G Iacono; E Cardi; S de Virgiliis; F Cataldo; G De Angelis; S Musumeci; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

5.  Coeliac disease patients carry conserved HLA-DR3-DQ2 haplotypes revealed by association of TNF alleles.

Authors:  Andrew S Louka; Benedicte A Lie; Bente Talseth; Henry Ascher; Johan Ek; Audur H Gudjónsdóttir; Ludvig M Sollid
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

Review 6.  Celiac disease in the developing countries: a new and challenging public health problem.

Authors:  Francesco Cataldo; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

7.  Association analysis of the extended MHC region in celiac disease implicates multiple independent susceptibility loci.

Authors:  Richard Ahn; Yuan Chun Ding; Joseph Murray; Alessio Fasano; Peter H R Green; Susan L Neuhausen; Chad Garner
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

Review 8.  Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients.

Authors:  Giovanni Marasco; Giovanna Grazia Cirota; Benedetta Rossini; Lisa Lungaro; Anna Rita Di Biase; Antonio Colecchia; Umberto Volta; Roberto De Giorgio; Davide Festi; Giacomo Caio
Journal:  Nutrients       Date:  2020-09-02       Impact factor: 5.717

9.  TagSNP approach for HLA risk allele genotyping of Saudi celiac disease patients: effectiveness and pitfalls.

Authors:  Reham H Baaqeel; Babajan Banaganapalli; Hadiah Bassam Al Mahdi; Mohammed A Salama; Bakr H Alhussaini; Meshari A Alaifan; Yagoub Bin-Taleb; Noor Ahmad Shaik; Jumana Yousuf Al-Aama; Ramu Elango; Omar I Saadah
Journal:  Biosci Rep       Date:  2021-06-25       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.